Medication adherence

Among adolescents with type 1 diabetes, those with better self-care are more likely to have favorable glycated hemoglobin trajectories into early adulthood, study findings suggest.

The real-world STAY study suggests that people take GLP-1 receptor agonists more consistently and for longer if given a weekly rather than daily formulation.

Dulaglutide is associated with better treatment persistence and lower rates of treatment modification versus other glucagon-like peptide‑1 receptor agonists in people with type 2 diabetes, suggests a study of Swedish health registries.

People with diabetes who access an online self-management portal through mobile devices have better medication adherence and glycemic control than those with computer-only or no access to the portal, researchers report.

Offering free medications to patients who struggle to afford them improves adherence, but with mixed effects on surrogate disease outcomes, report the CLEAN Meds researchers.

Adherence to first-line diabetes medication, ascertained from prescription records, is the only routine clinical variable that is a strong indicator of people’s adherence to second-line treatment, say researchers.

Targeting specific populations of individuals with type 2 diabetes for intensive interventions to optimize their insulin use may result in better glycemic control than an untargeted approach, findings from the TARGIT-Diabetes trial suggest.

A substantial proportion of diabetes patients living in resource-poor settings intermittently discontinue insulin for a variety of different reasons, IDMPS study results suggest.

Patients who are not diligent about taking their antidiabetic medications during the first year after type 2 diabetes diagnosis are at increased risk for cardiovascular events and death over the subsequent years, research shows.

Data presented at the ADA’s 78th Scientific Sessions in Orlando, Florida, show that almost 60% of patients with type 2 diabetes stop treatment within 12 months of being diagnosed.

An EASD session on optimizing patient outcomes included research into the effect of guideline adherence, predictors of changes in medication adherence, and overtreatment of older people with diabetes.

Adherence to lipid-lowering drugs is crucial for reducing cardiovascular disease risk among patients with type 2 diabetes, but taking only some of the prescribed medication is better than none at all, study results suggest.

An online game delivering diabetes self-management education helps improve glycemic control in patients with type 2 diabetes, study results suggest.